UBS AM’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$1.37B Buy
12,750,070
+1,450,128
+13% +$156M 0.28% 67
2025
Q1
$1.14B Buy
11,299,942
+460,580
+4% +$46.5M 0.29% 69
2024
Q4
$968M Buy
10,839,362
+1,709,461
+19% +$153M 0.23% 78
2024
Q3
$765M Sell
9,129,901
-367,457
-4% -$30.8M 0.2% 92
2024
Q2
$731M Buy
9,497,358
+2,173,974
+30% +$167M 0.21% 87
2024
Q1
$502M Sell
7,323,384
-621,344
-8% -$42.6M 0.18% 107
2023
Q4
$459M Buy
7,944,728
+266,715
+3% +$15.4M 0.18% 115
2023
Q3
$405M Buy
7,678,013
+441,622
+6% +$23.3M 0.18% 108
2023
Q2
$362M Hold
7,236,391
0.18% 121
2023
Q1
$362M Sell
7,236,391
-916,301
-11% -$45.8M 0.18% 121
2022
Q4
$377M Buy
8,152,692
+2,555,480
+46% +$118M 0.2% 111
2022
Q3
$217M Sell
5,597,212
-52,481
-0.9% -$2.03M 0.12% 188
2022
Q2
$211M Sell
5,649,693
-17,851
-0.3% -$665K 0.11% 199
2022
Q1
$251M Sell
5,667,544
-26,416
-0.5% -$1.17M 0.11% 204
2021
Q4
$242M Sell
5,693,960
-664,364
-10% -$28.2M 0.09% 232
2021
Q3
$276M Sell
6,358,324
-360,758
-5% -$15.7M 0.11% 185
2021
Q2
$287M Sell
6,719,082
-1,480,581
-18% -$63.3M 0.12% 175
2021
Q1
$317M Buy
8,199,663
+453,168
+6% +$17.5M 0.14% 150
2020
Q4
$278M Buy
7,746,495
+780,919
+11% +$28.1M 0.13% 156
2020
Q3
$266M Buy
6,965,576
+231,354
+3% +$8.84M 0.14% 139
2020
Q2
$236M Buy
6,734,222
+1,404,025
+26% +$49.3M 0.14% 141
2020
Q1
$174M Buy
5,330,197
+887,942
+20% +$29M 0.13% 165
2019
Q4
$201M Buy
4,442,255
+55,369
+1% +$2.5M 0.12% 179
2019
Q3
$179M Buy
4,386,886
+215,309
+5% +$8.76M 0.12% 184
2019
Q2
$179M Sell
4,171,577
-117,665
-3% -$5.06M 0.13% 173
2019
Q1
$165M Buy
4,289,242
+3,789
+0.1% +$145K 0.12% 190
2018
Q4
$151M Buy
4,285,453
+182,308
+4% +$6.44M 0.13% 177
2018
Q3
$158M Buy
4,103,145
+3,487
+0.1% +$134K 0.12% 200
2018
Q2
$134M Sell
4,099,658
-96,195
-2% -$3.15M 0.1% 225
2018
Q1
$115M Buy
4,195,853
+492,287
+13% +$13.4M 0.09% 257
2017
Q4
$91.8M Buy
3,703,566
+31,171
+0.8% +$773K 0.08% 287
2017
Q3
$107M Buy
3,672,395
+69,263
+2% +$2.02M 0.1% 234
2017
Q2
$99.9M Buy
3,603,132
+167,326
+5% +$4.64M 0.1% 246
2017
Q1
$85.4M Buy
3,435,806
+286,705
+9% +$7.13M 0.09% 260
2016
Q4
$68.1M Sell
3,149,101
-1,924,113
-38% -$41.6M 0.08% 279
2016
Q3
$121M Buy
5,073,214
+1,013,316
+25% +$24.1M 0.13% 171
2016
Q2
$94.9M Buy
4,059,898
+1,042,069
+35% +$24.4M 0.11% 205
2016
Q1
$56.8M Sell
3,017,829
-62,820
-2% -$1.18M 0.07% 323
2015
Q4
$56.8M Sell
3,080,649
-677,444
-18% -$12.5M 0.06% 317
2015
Q3
$61.7M Sell
3,758,093
-402,981
-10% -$6.61M 0.07% 310
2015
Q2
$73.7M Buy
4,161,074
+45,305
+1% +$802K 0.07% 301
2015
Q1
$73.1M Sell
4,115,769
-371,014
-8% -$6.59M 0.07% 307
2014
Q4
$59.5M Buy
4,486,783
+47,529
+1% +$630K 0.06% 362
2014
Q3
$52.4M Sell
4,439,254
-26,788
-0.6% -$316K 0.05% 385
2014
Q2
$57M Buy
4,466,042
+90,923
+2% +$1.16M 0.06% 354
2014
Q1
$59.2M Buy
4,375,119
+189,207
+5% +$2.56M 0.06% 327
2013
Q4
$50.3M Buy
4,185,912
+149,549
+4% +$1.8M 0.06% 347
2013
Q3
$47.4M Buy
4,036,363
+47,536
+1% +$558K 0.06% 335
2013
Q2
$37M Buy
+3,988,827
New +$37M 0.05% 396